My post yesterday regarding PhRMA's response to my letter citing a violation of its DTC Guiding Principles by Sepracor generated a few comments.

One comment by a fellow blogger got me thinking about how PhRMA's handling -- or mishandling -- of its oversight and transparency regarding the DTC Guidelines might play out in the upcoming elections.

For more on this and my continuing correspondence with Emily, Erin, and Nina at PhRMA, please see today's post to Pharma Marketing Blog.

For more posts in related topic areas, see:

• DTC Advertising
• PhRMA
• Public Relations/Image

| Return to Pharma Marketing Blog Topics |